 HOUSTON VANCOUVER, British Columbia--BUSINESS WIRE--- ABCL antibodies--Tachyon and AbCellera Collaborate to Develop Novel Antibody Therapeutic Targeting TGF-β Superfamily Member for the Treatment of Cancer 